Product
Recombinant Humanized Anti-IL-36R Monoclonal antibody
Aliases
no other names, Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase Ic, Randomized, Double-blind, Placebo-controlled, Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HB0034 in Adult Healthy Subjects.Status: Completed, Estimated PCD: 2023-06-09